Pfizer, Inc. (PFE) financial statements (2021 and earlier)

Company profile

Business Address 235 E 42ND ST
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,8309,08712,91211,61918,83317,23913,431
Cash and cash equivalents1,3052,7851,7841,9371,1393,5592,704
Short-term investments8,5256,30211,1289,68217,69413,68010,727
Receivables8,7249,4399,7939,5998,02510,0249,873
Inventory, net of allowances, customer advances and progress billings8,2838,2228,2338,0297,5088,1848,074
Inventory8,2838,2228,2338,0297,5088,1848,074
Disposal group, including discontinued operation21299,8779,8779,725  
Other current assets2,6002,9542,5352,5672,4612,4502,343
Other undisclosed current assets3,3453,7283,7233,5993,3743,6863,582
Total current assets:32,80333,45947,07345,29049,92641,58337,303
Noncurrent Assets
Inventory, Noncurrent714677646637618576615
Operating lease, right-of-use asset1,3131,3061,273 
Property, plant and equipment13,96713,70113,52113,46713,38514,03613,919
Long-term investments and receivables3,0142,7232,9052,8592,7676,4446,595
Long-term investments3,0142,7232,9052,8592,7676,4446,595
Intangible assets, net (including goodwill)94,02397,66086,37687,52688,622100,920102,420
Goodwill58,65358,66553,35253,48753,41155,61455,836
Intangible assets, net (excluding goodwill)35,37038,99533,02434,03935,21145,30646,584
Other noncurrent assets4,4504,9204,3884,3332,7992,9802,896
Other undisclosed noncurrent assets17,20516,000171,3091,3051,2991,232
Total noncurrent assets:134,686136,987109,126110,131109,496126,255127,677
TOTAL ASSETS:167,489170,446156,199155,421159,422167,838164,980
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,02410,1959,4047,80210,38311,13710,448
Accounts payable4,2203,9424,0024,1564,6744,2974,196
Employee-related liabilities2,7202,3691,8751,7972,3972,0961,791
Taxes payable9801,8921,5361,8491,2652,7812,481
Interest and dividends payable2,1041,9921,991 2,0471,9631,980
Debt16,19516,61710,5079,4108,8317,38511,583
Other liabilities11,08310,16010,11010,27610,75310,49010,125
Other undisclosed current liabilities222,0091,9351,8911 
Total current liabilities:37,30436,97432,03029,42331,85829,01332,156
Noncurrent Liabilities
Long-term debt and lease obligation35,95536,04436,16835,73332,90933,65228,935
Long-term debt, excluding current maturities35,95536,04436,16835,73332,90933,65228,935
Liabilities, other than long-term debt30,78332,03328,07627,51527,19727,99728,023
Deferred income tax liabilities5,5786,7243,180 
Liability for uncertainty in income taxes12,12612,50412,42114,71214,73715,28915,597
Liability, pension and other postretirement and postemployment benefits6,7626,4246,2926,4576,6106,3416,479
Other liabilities6,3176,3816,1836,3465,8506,3675,947
Other undisclosed noncurrent liabilities   3,5923,7005,5125,742
Total noncurrent liabilities:66,73868,07764,24466,84063,80667,16162,700
Total liabilities:104,042105,05196,27496,26395,66496,17494,856
Stockholders' equity
Stockholders' equity attributable to parent, including:63,14365,10359,56858,80663,40771,31969,778
Preferred stock17181819192020
Common stock468468468468467466465
Treasury stock, value(110,801)(110,795)(110,786)(110,781)(101,610)(96,574)(95,463)
Additional paid in capital87,42887,09986,96386,63586,25385,82884,898
Accumulated other comprehensive loss(11,640)(11,801)(11,535)(10,923)(11,275)(10,417)(10,003)
Retained earnings97,670100,11394,44093,38889,55491,99589,860
Other undisclosed stockholders' equity attributable to parent11  (1)11
Stockholders' equity attributable to noncontrolling interest303293357352351346346
Other undisclosed stockholders' equity1 (1)  (1) 
Total stockholders' equity:63,44765,39659,92459,15863,75871,66470,124
Other undisclosed liabilities and equity (1)1    
TOTAL LIABILITIES AND EQUITY:167,489170,446156,199155,421159,422167,838164,980

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues12,68812,68013,26413,11813,97713,29813,466
Cost of revenue
(Cost of Goods and Services Sold)
(2,608)(2,602)(2,576)(2,433)(3,075)(2,694)(2,916)
Gross profit:10,08010,07810,68810,68510,90210,60410,550
Operating expenses(7,516)(5,843)(5,238)(5,088)(7,336)(5,585)(5,383)
Operating income:2,5644,2355,4505,5973,5665,0195,167
Nonoperating income (expense)(3,042)7,768(126)(92)(3,259)414551
Investment income, nonoperating(1)8,087     
Other nonoperating income (expense)(3,041)(319)(126)(92)(3,259)414551
Interest and debt expense (409)(389)(138)943(310)(326)
Income (loss) from continuing operations before equity method investments, income taxes:(478)11,5944,9355,3671,2505,1235,392
Other undisclosed loss from continuing operations before income taxes(1,030)(867)(794)(1,044)(2,196)(946)(865)
Income (loss) from continuing operations before income taxes:(1,508)10,7274,1414,323(946)4,1774,527
Income tax expense (benefit)1,182(3,047)915(433)564(66)(648)
Other undisclosed loss from continuing operations(1)  (1)(1)  
Income (loss) from continuing operations:(327)7,6805,0563,889(383)4,1113,879
Income from discontinued operations 4   11 
Income (loss) before gain (loss) on sale of properties:(327)7,6845,0563,889(383)4,1223,879
Other undisclosed net income1      
Net income (loss):(326)7,6845,0563,889(383)4,1223,879
Net loss attributable to noncontrolling interest(10)(4)(10)(6)(11)(8)(7)
Other undisclosed net income attributable to parent   11  
Net income (loss) attributable to parent:(336)7,6805,0463,884(393)4,1143,872
Other undisclosed net loss available to common stockholders, basic(1) (1)(1)(1) (1)
Net income (loss) available to common stockholders, basic:(337)7,6805,0453,883(394)4,1143,871
Other undisclosed net income available to common stockholders, diluted1 111 1
Net income (loss) available to common stockholders, diluted:(336)7,6805,0463,884(393)4,1143,872

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):(326)7,6845,0563,889(383)4,1223,879
Other comprehensive income (loss)160(275)(610)348(859)(422)(613)
Other undisclosed comprehensive income    1  
Comprehensive income (loss):(166)7,4094,4464,237(1,241)3,7003,266
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(10)6(12)(1)(11)(8)4
Other undisclosed comprehensive income, net of tax, attributable to parent     8 
Comprehensive income (loss), net of tax, attributable to parent:(176)7,4154,4344,236(1,252)3,7003,270

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: